124018 Sigma-AldrichAkt Inhibitor VIII, Isozyme-Selective, Akti-1/2 - CAS 612847-09-3 - Calbiochem
Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2, CAS 612847-09-3, is a cell-permeable, reversible & selective inhibitor of Akt1/Akt2 (IC50 = 58 nM and 210 nM for Akt1 & Akt2, respectively),
More>> Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2, CAS 612847-09-3, is a cell-permeable, reversible & selective inhibitor of Akt1/Akt2 (IC50 = 58 nM and 210 nM for Akt1 & Akt2, respectively), Less<<Synonymes: 1,3-Dihydro-1-(1-((4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one, Akti-1/2
Produits recommandés
Aperçu
Replacement Information |
---|
Tableau de caractéristiques principal
CAS # | Empirical Formula |
---|---|
612847-09-3 | C₃₄H₂₉N₇O |
Prix & Disponibilité
Référence | Disponibilité | Conditionnement | Qté | Prix | Quantité | |
---|---|---|---|---|---|---|
124018-1MG |
|
Ampoule plast. | 1 mg |
|
— | |
124018-5MG |
|
Flacon en verre | 5 mg |
|
— |
Description | |
---|---|
Overview | A cell-permeable and reversible quinoxaline compound that potently and selectively inhibits Akt1/Akt2 activity (IC50 = 58 nM, 210 nM, and 2.12 µM for Akt1, Akt2, and Akt3, respectively, in in vitro kinase assays). The inhibition appears to be pleckstrin homology (PH) domain-dependent. It does not exhibit any inhibitory effect against PH domain-lacking Akts, or other closely related AGC family kinases, PKA, PKC, and SGK, even at concentrations as high as 50 µM. Overcomes Akt1/Akt2-mediated resistance to chemotherapeutics in tumor cells and is shown to block basal and stimulated phosphorylation/activation of Akt1/Akt2 both in cultured cells in vitro and in mice in vivo. A 10 mM (1 mg/181 µl) solution of Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 (Cat. No. 124017) in DMSO is also available. |
Catalogue Number | 124018 |
Brand Family | Calbiochem® |
Synonyms | 1,3-Dihydro-1-(1-((4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one, Akti-1/2 |
Product Information | |
---|---|
CAS number | 612847-09-3 |
ATP Competitive | N |
Form | Yellow solid |
Hill Formula | C₃₄H₂₉N₇O |
Chemical formula | C₃₄H₂₉N₇O |
Reversible | Y |
Structure formula Image | |
Quality Level | MQ200 |
Biological Information | |
---|---|
Primary Target | Akt1, Akt2, Akt3 |
Primary Target IC<sub>50</sub> | 58 nM, 210 nM, 2.12 µM against Akt1, Akt2, and Akt3, respectively, in in vitro kinase assays |
Purity | ≥95% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Référence | GTIN |
124018-1MG | 07790788048006 |
124018-5MG | 04055977205718 |
Documentation
Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 - CAS 612847-09-3 - Calbiochem FDS
Titre |
---|
Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 - CAS 612847-09-3 - Calbiochem Certificats d'analyse
Titre | Numéro de lot |
---|---|
124018 |
Références bibliographiques
Aperçu de la référence bibliographique |
---|
Calleja, V., et al. 2009. PLoS Biol. 7, e17. Logie, L., et al. 2007. Diabetes 56, 228. Barnett, S.F., et al. 2005. Biochem. J. 385, 399. DeFeo-Jones, D., et al. 2005. Mol. Cancer Ther. 4, 271. Zhao, Z., et al. 2005. Bioorg. Med. Chem. Lett. 15, 905. Lindsley, C.W., et al. 2005. Bioorg. Med. Chem. Lett. 15, 761. |
Brochure
Titre |
---|
Akt |
Posters
Titre |
---|
Human Kinome & InhibitorSelect™ Libraries |